0001179110-20-000809.txt : 20200127
0001179110-20-000809.hdr.sgml : 20200127
20200127183040
ACCESSION NUMBER: 0001179110-20-000809
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200124
FILED AS OF DATE: 20200127
DATE AS OF CHANGE: 20200127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dreier Ashley
CENTRAL INDEX KEY: 0001614957
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36568
FILM NUMBER: 20550957
MAIL ADDRESS:
STREET 1: 15 W. SCENIC POINTE DR., STE. 100
CITY: DRAPER
STATE: UT
ZIP: 84020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTHEQUITY, INC.
CENTRAL INDEX KEY: 0001428336
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
BUSINESS PHONE: 801-727-1000
MAIL ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHEQUITY INC
DATE OF NAME CHANGE: 20080227
4
1
edgar.xml
FORM 4 -
X0306
4
2020-01-24
0
0001428336
HEALTHEQUITY, INC.
HQY
0001614957
Dreier Ashley
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100
DRAPER
UT
84020
0
1
0
0
Executive, VP, CTO and CIO
Common Stock
2020-01-24
4
M
0
16250
24.36
A
53737
D
Common Stock
2020-01-24
4
M
0
4000
14.00
A
57737
D
Common Stock
2020-01-24
4
S
0
16194
70.8764
D
41543
D
Common Stock
2020-01-24
4
S
0
4056
71.5511
D
37487
D
Common Stock
2020-01-24
4
S
0
4964
70.8320
D
32523
D
Common Stock
2020-01-24
4
S
0
1779
71.5964
D
30744
D
Stock Option (right to buy)
24.36
2020-01-24
4
M
0
16250
0
D
2026-03-23
Common Stock
16250
16250
D
Stock Option (right to buy)
14
2020-01-24
4
M
0
4000
0
D
2024-07-30
Common Stock
4000
0
D
The option exercises and subsequent sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.26 to $71.25 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each transaction as set forth in footnotes (2), (3), (4), and (5) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.28 to $71.81 per share.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.34 to $71.32 per share.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.35 to $71.86 per share.
The option will become exercisable as to 16,250 shares on March 23, 2020.
The option is immediately exercisable
/s/ Ashley Dreier
2020-01-27